Conversion from Sandimmune to Neoral in stable liver graft recipients.
Pollard
S G
SG
Department of Transplantation Surgery, St. James's University Hospital, Leeds, United Kingdom.
Lodge
J P
JP
D000284:Administration, Oral; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D010865:Pilot Projects; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine